EE345 Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2-Months Is Cost Effective for the Treatment of HIV-1 in Spain
| Autor: | Moreno Guillén, S, Rivero, A, Ventayol, P, Falcó, V, Torralba, M, Schroeder, M, Neches, V, Vallejo-Aparicio, LA, Mackenzie, I, Turner, M, Harrison, C |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S122-S122 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect